Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Dawnzera (donidalorsen)
.
Show all posts
Showing posts with label
Dawnzera (donidalorsen)
.
Show all posts
Monday, January 5, 2026
FDA Approves Dawnzera (donidalorsen) as the First and Only RNA-targeted Prophylactic Treatment for Hereditary Angioedema
›
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the U.S. Food and Drug Administration (FDA) approval of Dawnzera (donidalorsen) for pro...
›
Home
View web version
